121 related articles for article (PubMed ID: 7996797)
1. Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells.
Pankewycz OG; Guan JX; Bolton WK; Gomez A; Benedict JF
Kidney Int; 1994 Sep; 46(3):748-58. PubMed ID: 7996797
[TBL] [Abstract][Full Text] [Related]
2. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.
Sharma K; Ziyadeh FN
Am J Physiol; 1994 Dec; 267(6 Pt 2):F1094-01. PubMed ID: 7810696
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator.
Sharma K; Ziyadeh FN
Diabetes; 1995 Oct; 44(10):1139-46. PubMed ID: 7556948
[TBL] [Abstract][Full Text] [Related]
4. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
5. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
[TBL] [Abstract][Full Text] [Related]
6. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
Ohashi S; Abe H; Takahashi T; Yamamoto Y; Takeuchi M; Arai H; Nagata K; Kita T; Okamoto H; Yamamoto H; Doi T
J Biol Chem; 2004 May; 279(19):19816-23. PubMed ID: 15004023
[TBL] [Abstract][Full Text] [Related]
9. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
12. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?
Zheng F; Cai W; Mitsuhashi T; Vlassara H
Mol Med; 2001 Nov; 7(11):737-47. PubMed ID: 11788787
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.
Sharma K; Jin Y; Guo J; Ziyadeh FN
Diabetes; 1996 Apr; 45(4):522-30. PubMed ID: 8603776
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.
Dai C; Liu Y
J Am Soc Nephrol; 2004 Jun; 15(6):1402-12. PubMed ID: 15153551
[TBL] [Abstract][Full Text] [Related]
16. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.
Han DC; Isono M; Chen S; Casaretto A; Hong SW; Wolf G; Ziyadeh FN
Kidney Int; 2001 Apr; 59(4):1315-23. PubMed ID: 11260392
[TBL] [Abstract][Full Text] [Related]
17. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.
Montero A; Munger KA; Khan RZ; Valdivielso JM; Morrow JD; Guasch A; Ziyadeh FN; Badr KF
Kidney Int; 2000 Nov; 58(5):1963-72. PubMed ID: 11044216
[TBL] [Abstract][Full Text] [Related]
18. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.
He CJ; Zheng F; Stitt A; Striker L; Hattori M; Vlassara H
Kidney Int; 2000 Nov; 58(5):1931-40. PubMed ID: 11044213
[TBL] [Abstract][Full Text] [Related]
20. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
